Eastern Pulmonary Conference 2017
Didactic lectures allow speakers to provide evidence based medical recommendations, updates and expert opinion in an efficient manner.
Accreditation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American College of Allergy, Asthma & Immunology (ACAAI) and Eastern Pulmonary Conference (EPC 2017). The American College of Allergy, Asthma and Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this live activity for a maximum of 14.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Funding
This activity is supported by independent educational grants from AstraZeneca, Circassia and Teva.
Target Audience
Practicing allergists, fellows-in-training, primary care physicians and allied healthcare providers in the field of allergy.
Learning Objectives
At the conclusion of this activity, participants should be able to:
- Discuss the causes and consequences of fixed airflow obstruction in asthma and recognize the concept of airway remodeling
- Outline the different phenotypic expressions of asthma such as eosinophilic-driven asthma, pauci-immune asthma and neutrophilic asthma.
- Discuss the phenotype of aspirin-exacerbated asthma and apply current understanding of this condition to disease recognition and treatment of this condition
- Describe the use of biomarkers to guide the current and future treatment options for asthma and discuss the optimal approaches to severe persistent asthma.
- Explain the clinical presentations, treatments and outcomes of the non-infectious pneumonia: hypersensitivity pneumonitis
Accreditation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American College of Allergy, Asthma & Immunology (ACAAI) and Eastern Pulmonary Conference (EPC 2017). The American College of Allergy, Asthma and Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this live activity for a maximum of 14.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Funding
This activity is supported by independent educational grants from AstraZeneca, Circassia and Teva.
Available Credit
- 14.75 AMA PRA Category 1 Credit™
- 14.75 Attendance